# FAMAR Group --- ## Pages - [Greeting 2025 FAMAR](https://www.famar-group.com/greeting-2025-famar/): https://www. famar-group. com/wp-content/uploads/2024/12/FAMAR_XMAS-CARD-VIDEO_FINAL-1. mp4https://www. famar-group. com/wp-content/uploads/2024/12/Famar_Greetings. mp4 - [Signup Form | Compass](https://www.famar-group.com/compass-profile-form/): Famar is a leading European Service Provide with expertise in pharmaceutical forms. Signup and receive our Product Compliance Services Leaflet for free. - [Compass](https://www.famar-group.com/compass/): Do you need support to navigate your way through the pharma industrial and regulatory landscape? Do you wish you had... - [Signup Form | Company Profile](https://www.famar-group.com/company-profile-form/): Famar is a leading European Service Provide with expertise in pharmaceutical forms. Signup and receive our Product Compliance Services Leaflet for free. - [Company Profile Signup-Thank You!](https://www.famar-group.com/company-profile-thank-you/): Famar is a leading European Service Provide with expertise in pharmaceutical forms. Thank you for your email. Download our R&D Services Leaflet. - [Product Compliance Services Signup-Thank You!](https://www.famar-group.com/product-compliance-services-thank-you/): Famar is a leading European Service Provide with expertise in pharmaceutical forms. Thank you for your email. Download our R&D Services Leaflet. - [Regulatory Services Signup-Thank You!](https://www.famar-group.com/regulatory-services-signup-thank-you/): Famar is a leading European Service Provide with expertise in pharmaceutical forms. Thank you for your email. Download our R&D Services Leaflet. - [Signup Form | Product Compliance Services](https://www.famar-group.com/product-compliance-services-signup/): Famar is a leading European Service Provide with expertise in pharmaceutical forms. Signup and receive our Product Compliance Services Leaflet for free. - [Signup Form | Regulatory Services](https://www.famar-group.com/regulatory-services-signup/): Famar is a leading European Service Provide with expertise in pharmaceutical forms. Signup and receive our Regulatory Services Leaflet for free. - [Signup Form | R&D Services](https://www.famar-group.com/rd-services-signup/): Famar is a leading European Service Provide with expertise in pharmaceutical forms. Signup and receive our R&D Services Leaflet for free. - [R&D-Services Signup-Thank You!](https://www.famar-group.com/rd-services-signup-thank-you/): Famar is a leading European Service Provide with expertise in pharmaceutical forms. Thank you for your email. Download our R&D Services Leaflet. - [R and D-Presentation](https://www.famar-group.com/r-and-d-presentation/): https://www. youtube. com/watch? v=46al5e7aghU - [Our R&D Expertise Tailored to your needs Thank You](https://www.famar-group.com/our-r-and-d-thank-you/): Famar is a leading European Service Provide with expertise in the majority of pharmaceutical forms offering expertise Tailored to your needs. - [Our R&D Expertise Tailored to your needs](https://www.famar-group.com/our-r-and-d-expertise-tailored-to-your-needs/): Famar is a leading European Service Provide with expertise in the majority of pharmaceutical forms offering expertise Tailored to your needs. - [Terms of use](https://www.famar-group.com/terms-of-use/): Welcome to the Famar website. Your access to and use of this site is subject to the following terms and... - [Cookies Policy](https://www.famar-group.com/cookies-policy/): COOKIES POLICY This Cookies Policy provides information in respect to the use of Cookies by the website and/or any mobile... - [Quality](https://www.famar-group.com/quality/): Famar business requires from its Quality Unit professionals to deliver Quality operational excellence and agility of Quality Services provided. - [R&D Services](https://www.famar-group.com/research-and-development-services/): Famar’s expert team ensures flawless research and development execution using Quality by Design and top Project Management practices. - [Timeline](https://www.famar-group.com/timeline/): Explore Famar’s timeline since 1949—key milestones, acquisitions, and growth shaping our legacy in pharmaceutical manufacturing and services. - [Privacy Policy](https://www.famar-group.com/privacy-policy-famar/): DATA PROTECTION POLICY «FAMAR GROUP» Famar Group (hereinafter referred to as the “Famar” or “we”) tries to offer you an... - [Manufacturing](https://www.famar-group.com/manufacturing/): Famar Group offers top-tier pharmaceutical, healthcare, and cosmetic manufacturing with advanced facilities and compliance across Europe. Learn more today. - [R&D](https://www.famar-group.com/rnd/): Explore Famar's R&D services, analytical development, and regulatory support for pharmaceutical innovation. - [Continuous Improvement](https://www.famar-group.com/continuous-improvement/): Explore Famar’s continuous improvement initiatives, operational excellence, innovation, and quality in pharmaceutical manufacturing and services. - [News](https://www.famar-group.com/news/): Stay up to date with the latest news from Famar Group, including key updates, partnerships, and innovations in pharmaceutical services. - [Careers](https://www.famar-group.com/careers/): Send us your CV - [Application](https://www.famar-group.com/application/): Apply to join Famar, submit your application to become part of our team dedicated to excellence in pharmaceutical manufacturing and services. - [Sustainability](https://www.famar-group.com/sustainability/): Explore Famar’s sustainability initiatives, focusing on environmental responsibility and social impact in pharmaceutical manufacturing. - [Quality Services](https://www.famar-group.com/quality-services/): Explore Famar’s quality services in pharmaceutical compliance solutions, risk management, and continuous improvement. - [Regulatory](https://www.famar-group.com/regulatory/): Famar’s Regulatory Affairs Team has extensive experience in providing support in Scientific and Technical Regulatory Affairs writing. - [Sites](https://www.famar-group.com/sites/): Explore Famar's network of manufacturing sites across Europe, providing high-quality pharmaceutical, healthcare, and cosmetic production with local expertise. - [Contact FAMAR](https://www.famar-group.com/contact-famar/): At FAMAR we are here for you. Get in touch with filling the form, choosing your area of interest. - [Logistics](https://www.famar-group.com/logistics/): Explore Famar’s logistics services: GDP-compliant storage, temperature-controlled transport, and efficient pharmaceutical distribution solutions. - [Mission](https://www.famar-group.com/mission/): Famar delivers innovative, accessible solutions to help Health & Personal Care industries improve the lives of patients and consumers worldwide. - [HomePage](https://www.famar-group.com/): Famar is a LEADING European provider of pharmaceutical manufacturing & development services with a legacy of 75 years of technology expertise. --- ## Posts --- ## News - [FAMAR Group announces acquisition of sterile manufacturing site in Homburg, Germany](https://www.famar-group.com/new/famar-group-announces-acquisition-of-sterile-manufacturing-site-in-homburg-germany/): 13 May 2025 – FAMAR Group, a leading European pharmaceutical CDMO, is pleased to announce the signature of an agreement... - [FAMAR achieves EcoVadis Gold](https://www.famar-group.com/new/famar-achieves-ecovadis-gold/): FAMAR achieves EcoVadis Gold – A Testament to Our ESG Leadership! At FAMAR, sustainability is not just a goal—it is... - [FAMAR welcomes Roberta Vigna to its Executive Team](https://www.famar-group.com/new/famar-welcomes-roberta-vigna-quality-leadership/): FAMAR, a leading European contract development and manufacturing organization, announces the appointment of its new Executive Team member: Roberta Vigna... - [FAMAR wins GOLD Better Stands Certificate at CPHI](https://www.famar-group.com/new/famar-s-stand-at-cphi-has-been-awarded-the-gold-better-stands-certificate-for-sustainability/): Celebrating Sustainability Excellence at CPHI! We are thrilled to announce that FAMAR’s stand at CPHI has been awarded the GOLD... - [Bravo Sustainability Dialogue & Awards 2024](https://www.famar-group.com/new/bravo-sustainability-dialogue-amp-awards-2024/): We are thrilled to announce that FAMAR has been honored with the 2024 Bravo Sustainability Dialogue & Awards in the... - [Dr. Riku Rautsola joins FAMAR as Executive Chairman](https://www.famar-group.com/new/famar-appoints-dr-riku-rautsola-executive-chairman/): We are pleased to announce the appointment of our new Executive Team member: Dr. Riku Rautsola as Executive Chairman of... - [FAMAR @ CPHI Milan 2024](https://www.famar-group.com/new/famar-cphi-milan-2024/): After three dynamic and highly productive days at CPHI Milan, we’re filled with gratitude and excitement for what’s ahead! A... - [Martin Lexa joins FAMAR as Group HR Director](https://www.famar-group.com/new/famar-appoints-martin-lexa-group-hr-director/): FAMAR, a leading European contract development and manufacturing organization, announces the appointment of its new Executive Team member: Martin Lexa... - [Celebrating 75 Years of Excellence at FAMAR!](https://www.famar-group.com/new/celebrating-75-years-of-excellence-at-famar/): Our People, Our Legacy, 75 Years of Excellence! We are thrilled to unveil the celebration of our 75th-anniversary! This milestone... - [FAMAR and D-sight collaboration on CMC & Clinical Batches](https://www.famar-group.com/new/new-collaboration-between-famar-and-d-sight-for-cmc-development-and-clinical-batch-manufacturing/): Barcelona, 13th May 2024. D-Sight, a pioneering spin-off company of Vall d’Hebron Research Institute (VHIR) dedicated to the discovery and... - [CDMO Leadership Awards 2024](https://www.famar-group.com/new/cdmo-leadership-awards-2024/): FAMAR is honored to be recognized with 2024 CDMO Leadership Awards in the categories of Capabilities, Expertise, Quality and Service... - [FAMAR & Lavipharm collaboration in pharma production](https://www.famar-group.com/new/new-collaboration-between-famar-and-lavipharm-joining-forces-in-the-production-of-pharmaceutical-products/): Athens, 23. 01. 2024 – FAMAR and Lavipharm, two prominent companies in the pharmaceutical industry, jointly announce their new collaboration.... - [FAMAR @ CPHI Barcelona 2023](https://www.famar-group.com/new/famar-cphi-barcelona-2023/): It has been three exciting and very productive days at CPHI Barcelona! We would like to thank our FAMAR team,... - [2023 CPHI Pharma Awards finalists](https://www.famar-group.com/new/2023-cphi-pharma-awards-finalists/): FAMAR team is excited to once again be exhibiting at one of the biggest events in the global pharma community.... - [New website for COMPASS by FAMAR](https://www.famar-group.com/new/new-website-for-compass-by-famar/): We are thrilled to announce the launch of a brand new website, for COMPASS by FAMAR. Our new business segment... - [New Video: Our People, Our Brand](https://www.famar-group.com/new/new-video-our-people-our-brand/): Our people are our brand! FAMAR’s new Video is live! This new Video is part of the ongoing evolution of... - [FAMAR was awarded for its Business Extroversion](https://www.famar-group.com/new/famar-was-awarded-for-its-business-extroversion/): A new distinction for FAMAR at the “Protagonists of the Greek Economy” event, which recognizes the valuable contribution of Greek... - [FAMAR @ DCATWeek 2023](https://www.famar-group.com/new/famar-dcatweek-2023/): FAMAR had a very successful DCATWeek 2023 in New York City. The global event served as an excellent opportunity for... - [Green Brand Awards 2023](https://www.famar-group.com/new/green-brand-awards-2023/): At FAMAR we are delighted to announce that we have been awarded at the Green Brand Awards 2023. More specifically,... - [CDMO Leadership Awards 2023](https://www.famar-group.com/new/cdmo-leadership-awards-2023/): FAMAR is honored to be recognized with 2023 CDMO Leadership Awards in the categories of Service, Quality, Capabilities, Expertise, Reliability... - [Famar R&D Pilot Plant GMP issuance](https://www.famar-group.com/new/famar-r-amp-d-pilot-plant-in-madrid-has-been-authorized-by-agencia-espanola-de-medicamentos-y-productos-sanitarios/): At FAMAR, we are pleased to announce that our new R&D Pilot Plant in Madrid, Spain has been inspected and... - [FAMAR awarded by EKPA for its contribution to Greek pharma](https://www.famar-group.com/new/famar-was-awarded-by-ekpa-for-its-long-term-contribution-to-the-greek-pharmaceutical-industry/): Famar was awarded by the National Kapodistrian University of Athens (EKPA), among other companies, for its long-term contribution to the... - [FAMAR @ CPhI Frankfurt 2022](https://www.famar-group.com/new/famar-cphi-frankfurt-2022/): Famar participated actively at CPHI Frankfurt, having three exciting and productive days! The received feedback was very positive regarding our... - [FAMAR awarded at Manufacturing Excellence Awards 2022](https://www.famar-group.com/new/famar-was-awarded-at-the-manufacturing-excellence-awards-2022/): At FAMAR we are delighted to announce that we have been awarded at the Manufacturing Excellence Awards 2022 with 5... - [FAMAR’s new website wins three global design awards](https://www.famar-group.com/new/new-website-wins-international-design-awards/): In April 2022, FAMAR’s new website has been designated as the winner of three international design awards. famar-group. com was... - [Peter Prock appointed Board Chairman by ECM Partners](https://www.famar-group.com/new/ecm-partners-inc-appoints-peter-prock-as-chairman-of-famar-group-board-of-directors/): Madrid, 28. 02. 2022 – ECM Partners Inc. , FAMAR’s major shareholder, announced today that Peter Prock is appointed as... - [Famar welcomes a new member to its Executive Team](https://www.famar-group.com/new/famar-welcomes-a-new-member-to-its-executive-team/): Famar, a leading European contract development and manufacturing organization, announces the appointment of its new Executive Team member: Patrick Flood... - [Famar welcomes new members to its Executive Team](https://www.famar-group.com/new/famar-welcomes-three-new-members-to-its-executive-team/): Athens, January 31, 2022 – Famar, a leading European contract development and manufacturing organization, announces the appointment of two new... - [ECM Partners and Metric Capital invest in Famar](https://www.famar-group.com/new/ecm-partners-and-metric-capital-partners-llp-announce-new-investment-in-famar/): Athens Greece, 29 November 2021 – Funds managed by ECM Partners (“ECM”) and Metric Capital Partners LLP (“MCP”) are pleased... - [Famar was awarded by Bayer](https://www.famar-group.com/new/7372/): Famar was awarded by Bayer for its outstanding collaboration for the project “Oasis” in the «Igniting Networks Awards 2021». Oasis,... - [New Corporate Video](https://www.famar-group.com/new/new-corporate-video/): FAMAR’s new Corporate Video is live! The new Corporate Video is part of the ongoing evolution of Famar’s brand. It... - [Famar @ CPhI Worldwide 2021](https://www.famar-group.com/new/famar-cphi-worldwide-2021-in-milan/): Famar exceeded expectations at CPhI Worldwide 2021 in Milan with record attendance of meetings despite the pandemic. The received feedback... - [FAMAR awarded at the Manufacturing Excellence Awards 2021](https://www.famar-group.com/new/famar-at-the-manufacturing-excellence-awards/): FAMAR has been awarded with two of the highest distinctions at the Manufacturing Excellence Awards 2021, organized by BOUSSIAS. More... - [New Famar's Chief Executive Officer](https://www.famar-group.com/new/new-famar-chief-executive-officer/): Kostas Rengis has been appointed Chief Executive Officer of FAMAR in August 2021. Kostas Rengis has been a member of... - [Famar stands with those affected by the fires](https://www.famar-group.com/new/famar-stands-by-all-those-people-affected-by-the-fires/): It is with awe that we watch the catastrophic fires and the extreme weather conditions that prevail in our country.... - [FAMAR awarded for solidarity & results during 2010–2020](https://www.famar-group.com/new/famar-awarded-solidarity-turnaround-2010-2020/): Famar has been awarded at the “Golden Protagonists of the Greek Economy | Decade Awards for 2010 – 2020”, organized... - [Famar to attend CPhI Worldwide in Milan, 9–11/11](https://www.famar-group.com/new/famar-will-participate-in-the-cphi-worldwide/): Famar will participate actively in the CPhI Worldwide from 9th to 11th of November, in Fiera Milano, Italy. Join us... - [10 Most Promising Contract Manufacturing Companies 2021](https://www.famar-group.com/new/the-10-most-promising-contract-manufacturing-companies-2021/): Famar stands out by providing excellence in Contract Development & Manufacturing services and is well-deserved one of “The 10 Most... - [Famar to Distribute COVID-19 Vaccine to Remote Greek Centers](https://www.famar-group.com/new/famar-covid-19-vaccine-distribution/): Famar is actively participating in the global mobilization to confront and stop the Covid-19 pandemic by undertaking the vital task... - [FAMAR & Medicom Announce BIMATOPROST Dossier Buy](https://www.famar-group.com/new/famar-medicom-acquisition-bimatoprost/): 09/02/2021 PRESS ANNOUNCEMENT Medicom Healthcare Limited (Medicom) and Famar Health Care Services Madrid (Famar) are pleased to announce the signing... - [CEO’s interview with “BusinessNews” magazine](https://www.famar-group.com/new/famar-ceo-interview-businessnews/): 08/12/2020 The 1st interview of FAMAR CEO Ian Cooper in the BusinessNews magazine is online! A very interesting positioning regarding... - [FAMAR awarded for contribution to Greece’s pandemic fight](https://www.famar-group.com/new/famar-award-social-responsibility-greece/): Famar participated in the annual “Salus2020 & The Kind Hearts” meeting that took place on Tuesday, October 27, organized by... - [FAMAR joins CPhI Festival of Pharma as virtual exhibitor](https://www.famar-group.com/new/famar-exhibitor-cphl-festival-of-pharma/): This year, under the current restrictions due to the COVID-19 global pandemic, FAMAR was an Exhibitor of the virtual CPhI... - [York and Elements Capital Acquire Famar in 3 countries](https://www.famar-group.com/new/york-elements-acquisition-famar/): Funds managed by York Capital Management (York) and Elements Capital Management (ECM) have together completed the acquisition of the southern... - [Delpharm acquires five Famar sites in FR, CA & Netherlands](https://www.famar-group.com/new/delpharm-acquisition-of-5-famar-sites/): Press release Delpharm and the Famar Group announce the acquisition by Delpharm of 5 manufacturing sites in France, Canada and... - [Ecovadis 2016 Assessment](https://www.famar-group.com/new/ecovadis-2016-assessment/): Pleased to announce that Famar Group has been awarded for the 2nd consecutive year at the Silver level by Ecovadis,... - [Famar received the Gold Recognition by Ecovadis](https://www.famar-group.com/new/ecovadis-gold-recognition/): Consistent to its goal to become a leading manufacturer and service provider to the Health & Personal Care Industry, Famar... - [Silver Recognition awarded to Famar by Ecovadis](https://www.famar-group.com/new/famar-silver-recognition-by-ecovadis/): In line with Famar’s strategic goal to become the leading manufacturer and service provider to the Health & Personal Care... - [FAMAR Serialization Project](https://www.famar-group.com/new/famar-serialization-project/): Regulatory authorities have defined (or are in the process of defining) requirements for the serialization for pharmaceutical products and tamper... - [FAMAR launches Manufacturing Science & Technology unit](https://www.famar-group.com/new/famar-manufacturing-science-tech-organization/): FAMAR launching Manufacturing Science & Technology organization Within the frame of our continuing effort to strengthen Quality and Knowledge management,... - [Famar announces new sterile area start-up and expansion](https://www.famar-group.com/new/famar-expansion-new-sterile-area-madrid/): Famar is pleased to announce the successful certification and start of its new sterile area at its Madrid site. This... - [Famar Integrates Madrid Site, Expands Sterile Capacity](https://www.famar-group.com/new/famar-integration-madrid-operations-expansion/): The integration of the Sanofi-Aventis manufacturing site in Madrid within Famar network is now official. As of July 1st the... - [FAMAR receives EFQM “Commitment to Excellence” award](https://www.famar-group.com/new/efqm-commitment-to-excellence-famar/): Famar received its first Recognition in the EFQM Levels of Excellence. The division “Logistics Services” of Famar succeeded in meeting... --- ## Sites - [R&D Centers](https://www.famar-group.com/site/rnd/): The 2 R&D centres of excellence in Alcorcón, Spain and in Avlonas, Greece are specialized in the development of medicinal and consumer care products. - [Thiva](https://www.famar-group.com/site/thiva/): The FAMAR distribution centre, located in Thiva was built in 2005 and covers a total surface of 26.000 m² with a storage capacity of 34.000 pallets. - [Alcorcon](https://www.famar-group.com/site/alcorcon/): Famar’s Alcorcon (Madrid) site is a customer-focused facility supplying diverse pharmaceutical products to global and local partners. - [Alimos](https://www.famar-group.com/site/alimos/): Famar's Alimos site in Greece manufactures sterile injectables and eye drops, with excellent service and regulatory performance. - [Anthoussa](https://www.famar-group.com/site/anthoussa/): Famar's Anthoussa site in Greece manufactures solid dosage pharmaceuticals, delivering high-quality service and building long-term partnerships. - [Avlonas 49](https://www.famar-group.com/site/avlonas-49/): Famar's Avlonas 49 site in Greece manufactures liquid and semi-solid pharmaceuticals, and packages solid doses with strong quality. - [Avlonas 48](https://www.famar-group.com/site/avlonas-48/): Famar's Avlonas 48 site in Greece manufactures personal hygiene, hair care, and facial care products, along with specialized packaging solutions. - [Baranzate](https://www.famar-group.com/site/baranzate/): Famar's Baranzate site in Milan produces high-quality solid oral forms with strong audit performance and reliable, sustainable operations. --- ## Manufacturing - [High Potent Tablets](https://www.famar-group.com/manufacture/high-potent-tablets/): Famar offers manufacturing and packaging of high containment tablets at its dedicated unit in Alcorcon, Spain. This area is currently operating a thyroid hormone product (micro dosage). - [Effervescent Solid Dose](https://www.famar-group.com/manufacture/effervescent-solid-dose/): Famar offers manufacturing and packaging of high containment tablets at its dedicated unit in Alcorcon, Spain. This area is currently operating a thyroid hormone product (micro dosage). - [Suppositories](https://www.famar-group.com/manufacture/suppositories/): Famar has a long-standing expertise in the field of rectal and vaginal suppositories. - [Ampoules](https://www.famar-group.com/manufacture/ampoules/): Famar offers worldwide customized solutions for injectable ampoules meeting the high quality standards of pharmaceutical market. - [Multi-dose Sterile Liquids (Eye/Ear Drops, Nasal Sprays)](https://www.famar-group.com/manufacture/multi-dose-sterile-liquids/): Famar offers a wide range of nasal sprays and eye/ear drops manufacturing and filling capabilities for a variety of products. - [Semi-Solids](https://www.famar-group.com/manufacture/semi-solids/): Famar has extensive experience in manufacturing of Semi-Solids - [SOLID DOSE FORMS - Tablets](https://www.famar-group.com/manufacture/liquids-and-semisolids/): Through three manufacturing sites, Famar offers a wide variety of oral tablet product forms including specialty types such as multi-layer tablets. - [Liquids](https://www.famar-group.com/manufacture/liquids/): Famar has extensive experience in manufacturing of dermocosmetics and high-value consumer care liquid products under nitrogen protection. --- # # Detailed Content ## Pages - Published: 2024-12-04 - Modified: 2024-12-09 - URL: https://www.famar-group.com/greeting-2025-famar/ https://www. famar-group. com/wp-content/uploads/2024/12/FAMAR_XMAS-CARD-VIDEO_FINAL-1. mp4https://www. famar-group. com/wp-content/uploads/2024/12/Famar_Greetings. mp4 --- > Famar is a leading European Service Provide with expertise in pharmaceutical forms. Signup and receive our Product Compliance Services Leaflet for free. - Published: 2023-03-14 - Modified: 2023-03-16 - URL: https://www.famar-group.com/compass-profile-form/ COMPASS by FAMAR Fill in your email address and get the Compass by Famar Leaflet --- - Published: 2023-02-09 - Modified: 2025-05-13 - URL: https://www.famar-group.com/compass/ Do you need support to navigate your way through the pharma industrial and regulatory landscape? Do you wish you had fast access or on-demand advice from field-active pharma manufacturing experts? Do you wish you could use a leading CDMO’s industrial experience for ad hoc services? COMPASS LEAFLET CONTACT US FOR MORE INFOPrivacy Policy | Terms of use | Cookies Policy --- > Famar is a leading European Service Provide with expertise in pharmaceutical forms. Signup and receive our Product Compliance Services Leaflet for free. - Published: 2022-10-27 - Modified: 2023-10-25 - URL: https://www.famar-group.com/company-profile-form/ Company Profile Fill in your email address and get the Company Profile Leaflet --- > Famar is a leading European Service Provide with expertise in pharmaceutical forms. Thank you for your email. Download our R&D Services Leaflet. - Published: 2022-10-27 - Modified: 2023-03-14 - URL: https://www.famar-group.com/company-profile-thank-you/ Thank you! We sent you the Company Profile leaflet via email. --- > Famar is a leading European Service Provide with expertise in pharmaceutical forms. Thank you for your email. Download our R&D Services Leaflet. - Published: 2022-10-24 - Modified: 2023-03-14 - URL: https://www.famar-group.com/product-compliance-services-thank-you/ Thank you! We sent you the Product Compliance Services leaflet via email. --- > Famar is a leading European Service Provide with expertise in pharmaceutical forms. Thank you for your email. Download our R&D Services Leaflet. - Published: 2022-10-24 - Modified: 2023-10-10 - URL: https://www.famar-group.com/regulatory-services-signup-thank-you/ Thank you! We sent you the Regulatory Services leaflet via email. --- > Famar is a leading European Service Provide with expertise in pharmaceutical forms. Signup and receive our Product Compliance Services Leaflet for free. - Published: 2022-10-18 - Modified: 2023-03-14 - URL: https://www.famar-group.com/product-compliance-services-signup/ Product Compliance Services Fill in your email address and get the Product Compliance Services Leaflet --- > Famar is a leading European Service Provide with expertise in pharmaceutical forms. Signup and receive our Regulatory Services Leaflet for free. - Published: 2022-10-18 - Modified: 2023-10-10 - URL: https://www.famar-group.com/regulatory-services-signup/ Regulatory Services Fill in your email address and get the Regulatory Services Leaflet --- > Famar is a leading European Service Provide with expertise in pharmaceutical forms. Signup and receive our R&D Services Leaflet for free. - Published: 2022-10-17 - Modified: 2023-10-13 - URL: https://www.famar-group.com/rd-services-signup/ R&D Services Fill in your email address and get the R&D Services leaflet --- > Famar is a leading European Service Provide with expertise in pharmaceutical forms. Thank you for your email. Download our R&D Services Leaflet. - Published: 2022-10-17 - Modified: 2023-03-16 - URL: https://www.famar-group.com/rd-services-signup-thank-you/ Thank you! We sent you the R&D Services leaflet via email. --- - Published: 2022-10-14 - Modified: 2024-10-07 - URL: https://www.famar-group.com/r-and-d-presentation/ window. FB3D_CLIENT_DATA = window. FB3D_CLIENT_DATA || ;FB3D_CLIENT_DATA. push('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');window. FB3D_CLIENT_LOCALE && FB3D_CLIENT_LOCALE. render && FB3D_CLIENT_LOCALE. render;https://www. youtube. com/watch? v=46al5e7aghU --- > Famar is a leading European Service Provide with expertise in the majority of pharmaceutical forms offering expertise Tailored to your needs. - Published: 2022-06-14 - Modified: 2023-03-16 - URL: https://www.famar-group.com/our-r-and-d-thank-you/ Our R&D Expertise Tailored to your Needs Thank you for your Submission! Download White Paper --- > Famar is a leading European Service Provide with expertise in the majority of pharmaceutical forms offering expertise Tailored to your needs. - Published: 2022-04-20 - Modified: 2023-03-16 - URL: https://www.famar-group.com/our-r-and-d-expertise-tailored-to-your-needs/ home NewsCareers search Contact us open menu Our R&D ExpertiseTailored to your Needs Download the Whitepaper and learn how to help you with your next project About our new Plant With a constructed area of more than 1,000 m2, our new Plant is in compliance with the highest CGMP standards and equipped to house state-of-the-art technology that enables us to develop and scale up our customers' projects from benchlab of early phases to clinical trial manufacturing. All operations are under a strict level of containment that guarantees the safety of the personnel and the product and allows the production of HPAPI up to GMP conditions Safebridge 3A HPAPIS. Running projects of manufacturing GMP batches up to 30 Kg. Versatile Rooms Handling substances OEB-3, OEB-4, OEB-5By completing this short form you can download the document about the “GMP Pilot Plant offering new services and technologies” and initiate the conversation with us. FAMAR IS A LEADING EUROPEAN SERVICE PROVIDER WITH A LEGACY OF MORE THAN 70 YEARS OF EXPERTISE AND CAPABILITIES IN THE MAJORITY OF PHARMACEUTICAL FORMS Our know-how We offer our expertise in the full spectrum of pharmaceutical development and manufacturing services, raging from early development, through clinical trials, packaging, and logistics, to full commercial launch, and beyond. --- - Published: 2021-11-17 - Modified: 2022-10-25 - URL: https://www.famar-group.com/company-profile/ window. FB3D_CLIENT_DATA = window. FB3D_CLIENT_DATA || ;FB3D_CLIENT_DATA. push('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');window. FB3D_CLIENT_LOCALE && FB3D_CLIENT_LOCALE. render && FB3D_CLIENT_LOCALE. render; --- - Published: 2021-08-27 - Modified: 2021-10-18 - URL: https://www.famar-group.com/terms-of-use/ Welcome to the Famar website. Your access to and use of this site is subject to the following terms and conditions and all applicable laws, as amended/revised from time to time. By accessing or using this site, you acknowledge that you have read, understood and agreed to the terms of use. Use of website. The information provided on this site is for general informational and educational purposes. The entire content of the site is subject to copyright protection. Copyright © 2021 FAMAR Health Care Services. Therefore, you may freely browse the site, but you may only access, download or use information from this site, including any text, images, audio and video for your own non –commercial use. You may not distribute, modify, transmit, reuse, repost or use the information for commercial purposes without the prior written consent of Famar. With the exception of the foregoing limited authorization, no licence to or right in the information or any copyright of Famar or other party is conferred to you. By using this site, you agree not to disrupt or intercept the information posted on this site. You also agree not to attempt to circumvent any security features of this site and to abide by all applicable laws, rules and regulations. Intellectual Property. This site may contain or reference proprietary information, trademarks, technologies, processes or other proprietary rights of Famar, its affiliates and/or other parties. No license to or right in any such trademarks, technologies, processes and other proprietary rights of Famar its... --- - Published: 2021-08-27 - Modified: 2021-09-16 - URL: https://www.famar-group.com/cookies-policy/ COOKIES POLICY This Cookies Policy provides information in respect to the use of Cookies by the website and/or any mobile application operated by or on behalf of Famar Group (we”, “us” or “Famar”) and/or its affiliated companies (“Website”), who act as the Data Controller. We will also describe what options you may have regarding Cookies. This Cookies Policy forms part and is incorporated into the terms of use of the Website and may be subject to amendments from time to time. You are advised to check our Cookies Policy regularly to be informed of any updates. Relevant notifications on substantial amendments may also be displayed on our site. By visiting the Website, you agree to accept any changes made to this Policy. WHAT ARE COOKIES Cookies are small text files —usually consisting of letters and numbers—stored on your device by a website server. Cookies are distinguished in “Session Cookies” and “Persistent Cookies” depending on the time they remain stored on your device. “Session cookies” are stored on your device at the time you visit a website and are deleted automatically after you close your browser. “Persistent cookies” are stored on your device at the time you visit a website and remain stored after you close your browser. Persistent cookies will be activated again automatically when you open your browser and browse the internet. WHY WE USE COOKIES? We use cookies in order to make sure our site is working properly and give you the best browsing experience possible. Certain cookies... --- - Published: 2021-08-05 - Modified: 2022-12-01 - URL: https://www.famar-group.com/privacy-policy-famar/ DATA PROTECTION POLICY «FAMAR GROUP» Famar Group (hereinafter referred to as the “Famar” or “we”) tries to offer you an experience that meets the needs of our visitors, by using responsibly the information collected through our website. We are committed to respect your privacy and comply with applicable laws on data protection and privacy. Processing of your personal data is governed by these terms, by the relevant provisions of Greek and EU legal framework on data protection, including the General Data Protection Regulation 2016/679/EC and the relevant Decisions, Guidelines and Regulations issued by the Hellenic Data Protection Authority (HDPA). This Privacy Policy (the "Policy") may be subject to modifications. We advise you to regularly check our Data Protection Policy in order to remain informed and updated on any amendments. By visiting and navigating through our Website you agree to this Data Protection Policy as in force at the time. When substantial amendments are made we will ensure that a relevant notice is posted for visitors of our Website. This Policy explains how we collect, process and/or use information that we receive via our websites, as amended from time to time. This Policy also describes how we collect, process, use and share the personal information you provide us with. It also describes your choices regarding use, access, transfer, correction and deletion of your personal information. 1. Information we collect We collect information about you to provide our services. In order for us to best provide our services to you, to contact... --- --- ## Posts --- ## News - Published: 2025-05-13 - Modified: 2025-05-14 - URL: https://www.famar-group.com/new/famar-group-announces-acquisition-of-sterile-manufacturing-site-in-homburg-germany/ 13 May 2025 – FAMAR Group, a leading European pharmaceutical CDMO, is pleased to announce the signature of an agreement to acquire a sterile production site in Homburg (Saar), Germany, from MiP Pharma. The acquisition represents a strategic milestone in FAMAR’s growth journey, strengthening its footprint in high-value dosage forms and expanding its capabilities in aseptic and lyophilized fill & finish. The Homburg facility, which has recently undergone significant investment and modernization, will become an integral part of FAMAR’s international manufacturing network. When the transaction closes, FAMAR will operate 7 facilities across Europe, enhancing its ability to serve its customers with flexible, high-quality, and scalable production solutions. “The Homburg site offers world-class sterile infrastructure, newly installed QC and microbiology laboratories, and a skilled workforce,” said Konstantinos Rengis, CEO of FAMAR Group. “This investment aligns with our strategy to grow in differentiated dosage forms and expand our capacity to support global customers with manufacturing services of the highest standards. We are proud to welcome the Homburg team to the FAMAR family and look forward to building a strong future together”. As part of the transaction, approximately 100 employees will transfer to FAMAR, ensuring continuity and knowledge retention. The site will be developed into a multi-customer CDMO platform under FAMAR ownership, fully aligned with the company’s ambition to lead in complex and high-value pharmaceutical manufacturing. Dr. Friedrich Sernetz, CEO of MiP Pharma, highlighted the strategic importance of the sale: “Thanks to the investments, the Homburg facility has become an attractive site for... --- - Published: 2025-04-02 - Modified: 2025-05-14 - URL: https://www.famar-group.com/new/famar-achieves-ecovadis-gold/ FAMAR achieves EcoVadis Gold – A Testament to Our ESG Leadership! At FAMAR, sustainability is not just a goal—it is a commitment. In a time when ESG benchmarks are more rigorous than ever, where even improved performance does not always secure recognition, FAMAR has not only maintained but surpassed expectations, achieving the prestigious EcoVadis Gold medal at Group level. A remarkable leap forward: FAMAR Group has earned a place among the top 5% of companies assessed by EcoVadis worldwide. This recognition is a testament to our unwavering commitment to sustainability, ethical business practices, and corporate responsibility. This milestone reinforces our role as a pioneering CDMO, setting the standard in ESG excellence. We remain a trusted partner, delivering not just quality but responsibility at every step. A huge thank you to our teams for making this achievement possible! Together, we continue to drive meaningful change. --- - Published: 2025-01-06 - Modified: 2025-05-14 - URL: https://www.famar-group.com/new/famar-welcomes-roberta-vigna-quality-leadership/ FAMAR, a leading European contract development and manufacturing organization, announces the appointment of its new Executive Team member: Roberta Vigna as Senior Vice President Quality. Roberta brings over 25 years of extensive experience in pharmaceutical quality assurance and management. She has held senior leadership roles in prominent organizations in pharma sector. Throughout her career, Roberta has been instrumental in elevating quality standards, ensuring regulatory compliance, and fostering a culture of continuous improvement. --- - Published: 2024-12-13 - Modified: 2025-05-14 - URL: https://www.famar-group.com/new/famar-s-stand-at-cphi-has-been-awarded-the-gold-better-stands-certificate-for-sustainability/ Celebrating Sustainability Excellence at CPHI! We are thrilled to announce that FAMAR’s stand at CPHI has been awarded the GOLD Better Stands Certificate for sustainability! This recognition underscores our commitment to sustainable practices and environmental responsibility. Our GOLD certification reflects the collaborative efforts of our team and contractors, who ensured compliance with all sustainability criteria assessed onsite by specialists. We are inspired to keep pushing boundaries in sustainability across every aspect of our business. --- - Published: 2024-12-06 - Modified: 2025-05-14 - URL: https://www.famar-group.com/new/bravo-sustainability-dialogue-amp-awards-2024/ We are thrilled to announce that FAMAR has been honored with the 2024 Bravo Sustainability Dialogue & Awards in the Climate Change category! This prestigious recognition reflects our unwavering commitment to protecting the environment. At FAMAR, we continuously strive to reduce the environmental impact of our operations and develop innovative solutions that contribute to a more sustainable future. The award, based on evaluations by ESG professionals, reaffirms our dedication to driving meaningful change and building a greener world. We are proud of this achievement and remain committed to reducing our environmental footprint—not only within our activities but also throughout our value chain. Together, we are making sustainability a reality! --- - Published: 2024-10-31 - Modified: 2025-05-14 - URL: https://www.famar-group.com/new/famar-appoints-dr-riku-rautsola-executive-chairman/ We are pleased to announce the appointment of our new Executive Team member: Dr. Riku Rautsola as Executive Chairman of the Board of Directors. Riku brings over 40 years of proven track record in the biotech and CDMO industry across Europe, US and Asia. We welcome the experience and guidance he will bring to our organization. We also extend our gratitude to Peter Prock, who will remain on our Board of Directors, for his invaluable contributions and unwavering dedication over the years. Peter has been instrumental in steering FAMAR through significant milestones, and we look forward to his continued insights and guidance. This transition is reaffirming our commitment to excellence in serving our customers and communities. --- - Published: 2024-10-15 - Modified: 2025-05-14 - URL: https://www.famar-group.com/new/famar-cphi-milan-2024/ After three dynamic and highly productive days at CPHI Milan, we’re filled with gratitude and excitement for what’s ahead! A heartfelt thank you to our incredible FAMAR team, to our customers and partners, and to all those who stopped by our booth, for your valuable time and engaging discussions. Together, we’ve laid the groundwork for exciting new collaborations and initiatives. We can’t wait to kick off these projects, driving innovation and excellence forward! The future holds so much more, and we’re ready to take on new challenges and opportunities with you by our side. Stay tuned, because the best is yet to come! Looking forward to seeing everyone at CPHI Frankfurt next year! --- - Published: 2024-09-17 - Modified: 2025-05-13 - URL: https://www.famar-group.com/new/famar-appoints-martin-lexa-group-hr-director/ FAMAR, a leading European contract development and manufacturing organization, announces the appointment of its new Executive Team member: Martin Lexa as Group HR Director. In his role, Martin will be responsible for the entire people function across the Famar Group. Martin brings over 25 years of experience in Human Resources having worked in leadership roles in complex and large businesses across several industries, including pharmaceuticals, consumer health, and MedTech. His experience, having worked and lived in Germany, France, Sweden, and Switzerland, will be a valuable asset to our team. --- - Published: 2024-08-01 - Modified: 2025-05-14 - URL: https://www.famar-group.com/new/celebrating-75-years-of-excellence-at-famar/ Our People, Our Legacy, 75 Years of Excellence! We are thrilled to unveil the celebration of our 75th-anniversary! This milestone marks decades of innovation, dedication, and excellence. We commemorate FAMAR’s journey with a special anniversary tribute – honoring our heritage, our people, and our continued dedication to excellence. We are proud of our achievements and excited about what the future holds. Thank you to all our incredible team members, partners, and clients for being part of this journey! Enjoy the video on YouTube --- - Published: 2024-05-13 - Modified: 2025-05-14 - URL: https://www.famar-group.com/new/new-collaboration-between-famar-and-d-sight-for-cmc-development-and-clinical-batch-manufacturing/ Barcelona, 13th May 2024. D-Sight, a pioneering spin-off company of Vall d’Hebron Research Institute (VHIR) dedicated to the discovery and development of new innovative therapeutic approaches for the treatment of neurodegenerative diseases of the retina; is thrilled to announce its strategic partnership with Famar Group, a European contract manufacturing and development organization serving the pharmaceutical industry. This collaboration marks a significant milestone for both entities, as they join forces to accelerate the development and production of clinical batches for D-Sight's eye drops solution intended for the treatment of early stages of diabetic retinopathy. Leveraging Famar Group's state-of-the-art facilities and expertise in CMC and GMP manufacturing, D-Sight aims to streamline the production process and ensure the highest quality standards for its innovative therapeutic solutions. FAMAR has a 75-year track record of delivering quality and value to customers across all finished dosage forms including sterile liquids, solids, and semi-solids. The company has a workforce of 1,850 employees across a network of six manufacturing sites and two R&D centers in Spain, Italy, and Greece. FAMAR currently supplies 1. 700 different products to more than 80 international markets. Shaping the future of neurodegenerative diseases of the retina "We are excited to embark on this collaborative journey with Famar Group” said Carla Maté Goldar, CEO and co-founder of D-Sight. "Their reputation for excellence in manufacturing and their experience in pharmaceutical development in the ophthalmic sector aligns perfectly with our commitment to delivering safe and effective therapies to patients in need. This partnership represents a significant... --- - Published: 2024-04-08 - Modified: 2025-05-14 - URL: https://www.famar-group.com/new/cdmo-leadership-awards-2024/ FAMAR is honored to be recognized with 2024 CDMO Leadership Awards in the categories of Capabilities, Expertise, Quality and Service for the second consecutive year. FAMAR scored as Champion in the Service category. FAMAR scored as Top Performer in Innovation. We were also awarded the following Individual Attribute Awards as we exceeded customer expectations: - Accessible Senior Management - On-Time Delivery - Right First Time - Strength of Science The awards are based on customer feedback about the performance of the company’s contract manufacturing practices based on projects delivered in the last 18 months. More than 70 contract manufacturers were assessed on 23 performance metrics during the ISR’s annual Contract Manufacturing Quality Benchmarking survey. These awards are based on customer feedback and confirm our commitment to excellence and being a trusted CDMO partner. The CDMO Leadership Awards are presented by Outsourced Pharma and supported by Life Science Leader. --- - Published: 2024-01-23 - Modified: 2025-05-14 - URL: https://www.famar-group.com/new/new-collaboration-between-famar-and-lavipharm-joining-forces-in-the-production-of-pharmaceutical-products/ Athens, 23. 01. 2024 – FAMAR and Lavipharm, two prominent companies in the pharmaceutical industry, jointly announce their new collaboration. FAMAR is a leading provider of development and manufacturing services for pharmaceutical and cosmetic products (CDMO) and one of the major CDMO players in Europe. Lavipharm, a pioneer in pharmaceutical technology and globally renowned for its expertise in and contribution to enhancing patients’ quality of life for over a century, specializes in research and development, production, import, marketing and distribution of pharmaceuticals and healthcare products in Greece, with a strong international commercial presence. As part of this new collaboration, FAMAR will undertake production of two pharmaceutical products recently added into Lavipharm's portfolio. Specifically, FAMAR will serve as the contract manufacturer for Lavipharm's analgesic pharmaceutical products Lonarid N® and Lonalgal®. This collaboration confirms the strong developmental impact of both FAMAR and Lavipharm on the pharma industry. It represents a significant development for the domestic market, enhancing the competitiveness of Greek pharmaceutical companies. At the same time, it contributes to increasing the availability of high-quality pharmaceutical products, ensuring their consistent and efficient production, thus enhancing patients’ quality of life. Nikolaos Papapolitis, Chairman of the Board of Directors of FAMAR A. B. E. , stated, "The selection of FAMAR for the production of Lavipharm's two products reflects our commitment to providing the most innovative products and services that contribute to improving patients’ quality of life. It reaffirms our dedication to consistently remaining the most reliable and dynamic partner throughout our value chain. "... --- - Published: 2023-10-27 - Modified: 2024-12-13 - URL: https://www.famar-group.com/new/famar-cphi-barcelona-2023/ It has been three exciting and very productive days at CPHI Barcelona! We would like to thank our FAMAR team, everyone who visited our booth, connected with us and our customers and partners for making these amazing days a success! We are looking forward to the new projects that we will initiate together with you! Stay tuned for what's next on our journey of innovation and excellence. The best is yet to come! See you next year in Milano! --- - Published: 2023-10-18 - Modified: 2024-12-13 - URL: https://www.famar-group.com/new/2023-cphi-pharma-awards-finalists/ FAMAR team is excited to once again be exhibiting at one of the biggest events in the global pharma community. This year, we are delighted to be 2023 CPHI Pharma Awards finalists in two categories! Our Green Holistic Approach and Integrated System of Flash Audits have been shortlisted for the Sustainability and Regulatory categories, respectively. --- - Published: 2023-10-17 - Modified: 2024-12-13 - URL: https://www.famar-group.com/new/new-website-for-compass-by-famar/ We are thrilled to announce the launch of a brand new website, for COMPASS by FAMAR. Our new business segment is a testament to our commitment for transforming the way we offer agile and “ready-to-use” solutions and services as a leading CDMO. Explore the new website by clicking on the following link: https://compassbyfamar. com/ and stay connected with COMPASS by FAMAR --- - Published: 2023-09-18 - Modified: 2024-12-13 - URL: https://www.famar-group.com/new/new-video-our-people-our-brand/ Our people are our brand! FAMAR’s new Video is live! This new Video is part of the ongoing evolution of Famar’s brand. Mr. Konstantinos Rengis, CEO of FAMAR Group, stated: “I am proud and excited to announce the release of a new FAMAR video showcasing our recognized and awarded CDMO leadership in the categories of Service, Quality, Capabilities, Expertise, Reliability and Compatibility. With 70 years of experience in the industry, our company continues to progress, grow, and expand its offerings. This video highlights the expertise, passion and customer centric dedication of our people - our brand - to deliver the best possible services and innovative solutions to our customers. Watch the video, on YouTube, for a glance at our company's culture and working principles and how we integrate all our skills together to meet the needs of our customers. We are committed to customer success by delivering innovation through the great experience of our people, our brand. ” --- - Published: 2023-07-21 - Modified: 2024-12-13 - URL: https://www.famar-group.com/new/famar-was-awarded-for-its-business-extroversion/ A new distinction for FAMAR at the "Protagonists of the Greek Economy" event, which recognizes the valuable contribution of Greek companies to the development of the domestic economy. On July 17th, Famar had the honor of receiving the award in the Business Extroversion category. This is a recognition of our continuous efforts but also an incentive to aim higher. The Famar awards were received by the VP of Commercial Operations, Avra Gouveri. Famar is committed to continuously evolve and be active in strengthening our positive footprint in the Greek society and economy. --- - Published: 2023-03-27 - Modified: 2024-12-13 - URL: https://www.famar-group.com/new/famar-dcatweek-2023/ FAMAR had a very successful DCATWeek 2023 in New York City. The global event served as an excellent opportunity for our team to connect with the global Pharma community and discuss about Famar’s development and manufacturing capabilities. It was great to meet and catch up with our existing partners and discuss future new partnerships as we continue to advance the healthcare industry. Thank you to all who visited us! We look forward to innovate together. --- - Published: 2023-03-23 - Modified: 2024-12-13 - URL: https://www.famar-group.com/new/green-brand-awards-2023/ At FAMAR we are delighted to announce that we have been awarded at the Green Brand Awards 2023. More specifically, Famar received the Gold Award at the category Green Holistic Approach. We’re very proud of this industry recognition received that acknowledges and rewards our innovative efforts for a sustainable future and a better life for everyone! Working together for a greener, more sustainable world! --- - Published: 2023-03-14 - Modified: 2024-12-13 - URL: https://www.famar-group.com/new/cdmo-leadership-awards-2023/ FAMAR is honored to be recognized with 2023 CDMO Leadership Awards in the categories of Service, Quality, Capabilities, Expertise, Reliability and Compatibility. Additionally, we received the following individual attribute awards as we exceeded customer expectations: - Accessible Senior Management - Innovation - On-Time Delivery - Reputation - Right First Time - Strength of Science The awards are based on customer feedback about the performance of the company’s contract manufacturing practices based on projects delivered in the last 18 months. More than 70 contract manufacturers were assessed on 23 performance metrics during the ISR’s annual Contract Manufacturing Quality Benchmarking survey. These awards confirm our continued commitment to excellence and being a trusted CDMO partner. The CDMO Leadership Awards are presented by Outsourced Pharma and supported by Life Science Leader. --- - Published: 2023-03-10 - Modified: 2024-12-13 - URL: https://www.famar-group.com/new/famar-r-amp-d-pilot-plant-in-madrid-has-been-authorized-by-agencia-espanola-de-medicamentos-y-productos-sanitarios/ At FAMAR, we are pleased to announce that our new R&D Pilot Plant in Madrid, Spain has been inspected and authorized by Agencia Española de Medicamentos y Productos Sanitarios for solid pharmaceuticals forms. With a constructed area of more than 1,000 sqm the new Plant is equipped to house state-of-the-art technology to develop and scale-up projects from bench lab of early phases to clinical trial manufacturing. Our suites are designed to work under FDA standard GMP conditions while ensuring full conditions to handle Safebridge 3A HPAPIs guaranteeing the safety of the personnel and the quality of the product. Famar is clearly the right partner to deliver your High Potency Drug Development. --- - Published: 2023-01-30 - Modified: 2025-05-13 - URL: https://www.famar-group.com/new/famar-was-awarded-by-ekpa-for-its-long-term-contribution-to-the-greek-pharmaceutical-industry/ Famar was awarded by the National Kapodistrian University of Athens (EKPA), among other companies, for its long-term contribution to the Greek pharmaceutical industry and its progress. At the special event held by EKPA in honor of the Pharmaceutical Industry in Greece, on Tuesday, January 24, Famar received an honorary plaque for its significant presence in domestic production, its overall contribution to public health, the national economy and employment as well as its continuous collaboration with the Academy and the Department of Pharmacy of EKPA. The honorary plaque was received by Mr. Apostolos Sagiakos, CEO of Greece of the FAMAR Group. In the context of the event, 21 pharmaceutical companies were honored for their long-term presence in the country and for their cooperation with the Department of Pharmacy of EKPA. FAMAR has a 70-year track record of delivering quality and value to customers across all finished dosage forms including sterile liquids, solids, and semi-solids. FAMAR has a workforce of 1,850 employees across a network of six manufacturing sites and two R&D centres in Spain, Italy, and Greece. --- - Published: 2022-11-08 - Modified: 2024-12-13 - URL: https://www.famar-group.com/new/famar-cphi-frankfurt-2022/ Famar participated actively at CPHI Frankfurt, having three exciting and productive days! The received feedback was very positive regarding our presence and organization. A big thank you to our FAMAR team, our customers and partners for making these amazing days a success! It was such a great pleasure meeting our customers and potential new customers, face to face and discuss about new projects. Next year, Famar will be present once again as an Exhibitor in Barcelona! --- - Published: 2022-11-03 - Modified: 2025-05-13 - URL: https://www.famar-group.com/new/famar-was-awarded-at-the-manufacturing-excellence-awards-2022/ At FAMAR we are delighted to announce that we have been awarded at the Manufacturing Excellence Awards 2022 with 5 significant awards. More specifically, Famar received: - Gold Award at the category Effective Management & Production Systems - Gold Award at the category Environmental and Energy Policy - Silver Award at the category Innovation and Creativity - Silver Award at the category High Quality - Bronze Award at the category Employees’ Health & Safety We’re very proud of the industry recognition received that acknowledges and rewards our innovative business practices and commitment to excellence. --- - Published: 2022-04-13 - Modified: 2025-05-13 - URL: https://www.famar-group.com/new/new-website-wins-international-design-awards/ In April 2022, FAMAR’s new website has been designated as the winner of three international design awards. famar-group. com was relaunched on 25 October 2021 as part of the ongoing evolution of Famar’s brand. The website development won awards for Innovation, User Experience (UX) and User Interface (UI) design in the prestigious CSS Design Awards (CSSDA). CSSDA is an international leading web design and development award platform that honors and showcases website designers for work that pushes the boundaries of UI, UX and innovative development. The CSS Design Awards categories are judged by a public vote as well as a panel of experts from 33 countries. The new FAMAR website designed in cooperation with Sheepfish, received excellence in all three categories (UI, UX, and Innovation) from the public and an impressive judges’ score of 6. 88. Special Kudos certificate was also awarded for exemplary work that inspired professional recognition. View the website award at CSS Design Awards. --- - Published: 2022-02-28 - Modified: 2025-05-13 - URL: https://www.famar-group.com/new/ecm-partners-inc-appoints-peter-prock-as-chairman-of-famar-group-board-of-directors/ Madrid, 28. 02. 2022 – ECM Partners Inc. , FAMAR’s major shareholder, announced today that Peter Prock is appointed as the new Chairman of the Board of Directors of FAMAR Group, a leading European contract development and manufacturing organization. "I am delighted to be joining FAMAR as Chairman at such an exciting time for the company. FAMAR is an established player in the European CDMO sector and is known for its broad range of manufacturing capabilities, innovation, and its commitment to quality and to customers. I look forward to working closely with the board and management as we execute on our strategic growth plans" said Peter Prock. Peter Prock is a widely respected executive, who has held various management roles in the pharmaceutical sector. Prior to forming Albrecht, Prock & Partners in 2016, Peter was CEO of Polpharma Group from 2013 to 2015, Deputy CEO of Actavis and CFO of Ratiopharm Group before its acquisition by Teva. Peter started his career at Sandoz, where he held various positions in Austria, Spain, the USA, and Germany. He is a board member of several pharmaceutical companies. "We are delighted to have Peter lead the FAMAR board. Peter has an outstanding reputation in the industry and will play an important role in driving growth and value creation for all stakeholders," said Savvas Liasis, ECM Partners Inc Chairman and Co-Managing Partner. The FAMAR Group Board of Directors also welcomes a trusted FAMAR executive, Konstantinos Rengis, CEO of FAMAR. “I am very happy to be... --- - Published: 2022-02-25 - Modified: 2024-12-13 - URL: https://www.famar-group.com/new/famar-welcomes-a-new-member-to-its-executive-team/ Famar, a leading European contract development and manufacturing organization, announces the appointment of its new Executive Team member: Patrick Flood as Group HR Director. As of May 4th Patrick Flood will be responsible for all HR functions across FAMAR Group. Patrick brings 32 years of international HR experience, where his main assignments were with Firestone, Dunlop, Delphi Automotive and Lear Corporation. --- - Published: 2022-02-01 - Modified: 2025-05-13 - URL: https://www.famar-group.com/new/famar-welcomes-three-new-members-to-its-executive-team/ Athens, January 31, 2022 - Famar, a leading European contract development and manufacturing organization, announces the appointment of two new Executive Team members: Joan Fuste as Group Chief Financial Officer (CFO) and Jean-Charles Rousset as Group Chief Operating Officer (COO). As of January 17th Joan Fuste will be overseeing all the financial functions of the Group. Joan carries more than 17 years of international experience in pharma finance, having previously worked with Covis Pharma, Johnson & Johnson and Abbott Laboratories. Jean-Charles Rousset will assume his duties on February 21st. Jean-Charles will be responsible for the Group’s Manufacturing Operations, Supply Chain Functions, Purchasing, Engineering, Technical Services, Health & Safety and Continuous Improvement. Jean-Charles brings 24 years of manufacturing experience in the food and pharmaceutical industry, half of which in high-level managerial and executive positions at Aspen. “We are excited to welcome Joan and Jean-Charles to our executive team. They each bring extensive knowledge and experience that will help drive Famar’s continuing growth. ” Said Konstantinos Rengis, Group CEO of Famar. --- - Published: 2021-12-02 - Modified: 2025-05-13 - URL: https://www.famar-group.com/new/ecm-partners-and-metric-capital-partners-llp-announce-new-investment-in-famar/ Athens Greece, 29 November 2021 - Funds managed by ECM Partners (“ECM”) and Metric Capital Partners LLP (“MCP”) are pleased to announce a new investment in FAMAR (“FAMAR” or the “Company”), a European contract development and manufacturing organisation serving the pharmaceutical sector. Funds managed by ECM acquired FAMAR in March 2020 with a view of making the necessary investments to improve performance. Since then, FAMAR has seen material improvements in service and quality and the Company is now operating in line with the quality and services levels expected by its customer base. Savvas Liasis, Chairman and Co-Managing Partner at ECM, said: “We’re extremely pleased with FAMAR’s operational performance since making our initial investment. The results speak for themselves, and customer feedback has been very positive. Increasing our stake in the company to a majority equity position was the natural development for us, as we now take a longer term view of the firm. ” As part of the most recent transaction, ECM has increased its investment and ownership in FAMAR, while MCP has made a significant investment in FAMAR and expects to support the Company’s ambitions over the coming years. York Capital Management has realised its investment in the Company. John Sinik, Managing Partner of MCP, said: “We are pleased to be partnering with ECM and FAMAR’s management team to take the Company to the next level. Together, we are taking a long-term view and will work with FAMAR’s customers and stakeholders to grow the business in exciting areas. We... --- - Published: 2021-11-29 - Modified: 2024-12-13 - URL: https://www.famar-group.com/new/7372/ Famar was awarded by Bayer for its outstanding collaboration for the project “Oasis” in the «Igniting Networks Awards 2021». Oasis, the new Bepanthen Bepanthol Dry Skin platform, has been the largest and most complex dermatology innovation initiative of the last years. With modern multiple packaging formats, hosting fresh and novel formulations, the new product range has been successfully launched in 9 global markets within 2021. We truly believe that inspired teamwork and integrated partnership are the key enablers to success. Our teams worked with passion, commitment, transparency and trust, and together with Bayer we made this happen. Check our video award --- - Published: 2021-11-25 - Modified: 2024-12-13 - URL: https://www.famar-group.com/new/new-corporate-video/ FAMAR’s new Corporate Video is live! The new Corporate Video is part of the ongoing evolution of Famar’s brand. It focuses and highlights the new dynamics of our business offering. We also launch the FAMAR YouTube Channel that is a new addition to our social media and aims to host selected news and activities. Enjoy! --- - Published: 2021-11-17 - Modified: 2024-12-13 - URL: https://www.famar-group.com/new/famar-cphi-worldwide-2021-in-milan/ Famar exceeded expectations at CPhI Worldwide 2021 in Milan with record attendance of meetings despite the pandemic. The received feedback was very positive regarding our presence and organization. A big thank you to our clients, partners and Famar team for making these exciting and amazing days in CPHI a success! It was a great opportunity meeting our customers, the existing ones and the new potential ones, face to face and discuss about very interesting topics. Next year, Famar will be present once again as an Exhibitor in Frankfurt. --- - Published: 2021-10-08 - Modified: 2025-05-13 - URL: https://www.famar-group.com/new/famar-at-the-manufacturing-excellence-awards/ FAMAR has been awarded with two of the highest distinctions at the Manufacturing Excellence Awards 2021, organized by BOUSSIAS. More specifically, FAMAR is the Winner in the Pharmaceuticals & Cosmetics Industry Section with the “FAMAR Serialization and Tamper Evidence Project”, a pioneer project that FAMAR was among the first to initiate in Europe. FAMAR also received the GOLD award in the Quality Sector with the nominated project “FAMAR Innovating on Integrated Quality Management Systems via Digital Transformation – We Go Digital” on our Digitalization strategy roll out of Quality Management, Document Management and Training Management Systems’ at Group Level. A big thank you to all the teams that have developed and are working on these demanding and important projects, combining their talents and expertise with the knowhow, legacy and innovation mindset of Famar. FAMAR with more than 1. 800 employees delivers CDMO Services for more than 120 customers worldwide and is rapidly adapting to an ever-changing and highly demanding pharmaceutical environment, providing flexibility and innovative solutions to quickly meet the needs of its customers. --- - Published: 2021-10-06 - Modified: 2024-12-13 - URL: https://www.famar-group.com/new/new-famar-chief-executive-officer/ Kostas Rengis has been appointed Chief Executive Officer of FAMAR in August 2021. Kostas Rengis has been a member of the York/ECM team in the evaluation process of the FAMAR acquisition that was concluded in March 2020. From March 2020 until July 2021, he was the Chief Operating Officer of FAMAR. He first joined Famar in 2009, holding the position of Vice President Operations. Kostas brings 33 years of experience in highly demanding roles. Prior to joining Famar he held a number of executive positions. He has served as a Global Shavers Director at Group BIC and NE General Manager of Smithers RAPRA Ltd. He holds Degrees in Engineering and in Physics/Chemistry. --- - Published: 2021-08-06 - Modified: 2025-05-13 - URL: https://www.famar-group.com/new/famar-stands-by-all-those-people-affected-by-the-fires/ It is with awe that we watch the catastrophic fires and the extreme weather conditions that prevail in our country. With a sense of responsibility and duty to assist in dealing with the consequences and losses of this unprecedented situation, we declare as FAMAR and as Greeks our presence, wishing to assist with financial support for - Building construction in the affected areas - Support and provision of essential goods to families suffering from the fires - Support volunteer veterinarians and animal shelters - Contribution to reforestation and development of a Famar forest with oaks at a selected place in the affected areas - Voluntary gathering and distribution of clothing of Famar employees to people affected by the fires Let us all unite against this uninvited enemy and build in solidarity a wall of humanity to those who need us in these difficult times. Με δέος παρακολουθούμε τις καταστροφικές πυρκαγιές και τις ακραίες καιρικές συνθήκες που επικρατούν στη χώρα μας. Με αίσθημα ευθύνης και χρέος στο να συνδράμουμε στην αντιμετώπιση των συνεπειών και των απωλειών αυτής της πρωτόγνωρης κατάστασης, δηλώνουμε ως FAMAR και ως Έλληνες το δικό μας «παρών» επιθυμώντας να συνδράμουμε με οικονομική ενίσχυση για - Ανέγερση κτηρίου στις πληγείσες περιοχές - Στήριξη και παροχή ειδών πρώτης ανάγκης για τις οικογένειες των πυρόπληκτων - Συνδρομή σε καταφύγιο περίθαλψης ζώων και στήριξη εθελοντών κτηνίατρων - Δενδροφύτευση και συντήρηση άλσους FAMAR με βελανιδιές σε επιλεγμένο σημείο στις πληγείσες περιοχές - Εθελοντική δράση εργαζομένων Famar για τη συγκέντρωση και διανομή ρουχισμού και... --- - Published: 2021-07-21 - Modified: 2025-05-13 - URL: https://www.famar-group.com/new/famar-awarded-solidarity-turnaround-2010-2020/ Famar has been awarded at the "Golden Protagonists of the Greek Economy | Decade Awards for 2010 - 2020", organized by Direction Business Network, with the "Turnaround Business Award", for its financial performance and turnaround business results for 2010 - 2020. Additionally, Famar received the "Solidarity Excellence Award" for its significant contribution to the global mobilization towards fighting the Covid-19 pandemic, providing its services to the Greek government and distributing the Covid vaccines to all Greek remoted areas. The Famar awards were received by the VP of Commercial Operations, Avra Gouveri. Click here in order to read the Press Release. --- - Published: 2021-07-20 - Modified: 2025-05-13 - URL: https://www.famar-group.com/new/famar-will-participate-in-the-cphi-worldwide/ Famar will participate actively in the CPhI Worldwide from 9th to 11th of November, in Fiera Milano, Italy. Join us at CPhI Worldwide and visit our Stand 4G40, at Hall 4, to discover our innovative development and manufacturing solutions. We look forward to meeting you at the CPhI Worldwide 2021 hybrid event, either online or in-person! --- - Published: 2021-05-26 - Modified: 2025-05-13 - URL: https://www.famar-group.com/new/the-10-most-promising-contract-manufacturing-companies-2021/ Famar stands out by providing excellence in Contract Development & Manufacturing services and is well-deserved one of "The 10 Most Promising Contract Manufacturing Companies 2021". Click here in order to read the article. --- - Published: 2021-03-26 - Modified: 2025-05-13 - URL: https://www.famar-group.com/new/famar-covid-19-vaccine-distribution/ Famar is actively participating in the global mobilization to confront and stop the Covid-19 pandemic by undertaking the vital task of distributing vaccines throughout Greece, providing its services free of charge for the Greek government. With 70 years of experience in the development and production of pharmaceuticals for some of the largest pharmaceutical companies in the world and having the largest market share and unique know-how in the distribution of exclusively pharmaceutical and cosmetic products for Greece, Famar undertakes the role of the Greek government partner regarding the distribution of vaccines. The distribution of the vaccines to the most remote locations is indeed a technical challenge due to the very demanding storage and transport conditions but also due to the critical importance of the cargo to the fight against the Covid-19 pandemic. Famar is able to perform such a mission with strict compliance with the Good Distribution Practices due to the quality and size of our fleet, the highly trained work force accustomed to handle high value lifesaving pharmaceuticals, and the impeccable track record provided by its Quality System, a safe assurance to our Clients, Authorities and to the population in general who is counting on these medicines to progressively return back to a normal life. Famar's fleet will serve vaccination centers in Northern Greece and Thrace. Departing from the Center of Thessaloniki, covering the prefectures of Halkidiki, Serres, Drama, Kavala, Xanthi, Rodopi and Evros, reaching the most remote vaccination centers of the mainland. Famar is already investing and expanding... --- - Published: 2021-02-09 - Modified: 2025-05-13 - URL: https://www.famar-group.com/new/famar-medicom-acquisition-bimatoprost/ 09/02/2021 PRESS ANNOUNCEMENT Medicom Healthcare Limited (Medicom) and Famar Health Care Services Madrid (Famar) are pleased to announce the signing of an Asset Purchase Agreement (APA) for the acquisition by Medicom of the pharmaceutical dossier of BIMATOPROST 0. 3 mg/mL, 3ml, preservative free eye drop solution, developed by Famar R&D. Under this agreement, Medicom has acquired the ownership of the product dossier which is already registered in the UK and 5 EU countries with plans to commercialise the asset globally. Medicom and Famar have also entered into a long term Manufacturing and Supply Agreement (MSA), with Famar being the exclusive manufacturer of this product for Medicom for a minimum period of 5 years, under specific terms and conditions. Both organisations expect the first commercial launch of the product, branded Zimed®, in quarter 4 of 2021. This agreement is an important milestone for Famar as it marks the sale of its second own pharmaceutical dossier signifying a new era of continuous development and investments, under a new shareholders scheme. Simon Martin, CEO and Chairman of Medicom said, “Medicom Healthcare is the largest volume supplier of Ophthalmic dry eye drops to the NHS in the UK . We have embarked on an ambitious Global expansion plan to sign up new distributors of our novel Evolve® range of therapies specifically designed to protect the cornea from damage by unnecessary excipients that are a legacy of older technologies” he added, “The Glaucoma market globally is predicted to exceed $3. 8bn by 2026, Zimed® will... --- - Published: 2020-12-08 - Modified: 2025-05-13 - URL: https://www.famar-group.com/new/famar-ceo-interview-businessnews/ 08/12/2020 The 1st interview of FAMAR CEO Ian Cooper in the BusinessNews magazine is online! A very interesting positioning regarding FAMAR’s new era seen as the real opportunity through crisis and how FAMAR is facing the unprecedented challenge of Covid-19 and the new regularity that it imposes. Click here in order to read the interview. --- - Published: 2020-11-09 - Modified: 2025-05-13 - URL: https://www.famar-group.com/new/famar-award-social-responsibility-greece/ Famar participated in the annual "Salus2020 & The Kind Hearts" meeting that took place on Tuesday, October 27, organized by the New Times publishing, with the participation of all major pharmaceutical companies in Greece, as well as representatives of the Government and Greek Health Authorities. During the event, Famar was awarded for its social responsibility and contribution to the fight of the pandemic in Greece, with the initiative of producing hand sanitizers to be donated to health authorities and Famar employees. The Famar award was received by the Administrative Director, Apostolos Sagiakos who, during his speech, highlighted the new era of Famar, that now, with the new shareholders, has turned the page and repositions itself as the leader CDMO with the responsibility of giving back to the society during times of need. --- - Published: 2020-10-23 - Modified: 2025-05-13 - URL: https://www.famar-group.com/new/famar-exhibitor-cphl-festival-of-pharma/ This year, under the current restrictions due to the COVID-19 global pandemic, FAMAR was an Exhibitor of the virtual CPhI Festival of Pharma, which took place from 5 to 16 October 2020. The virtual event provided the global pharma community with a platform to meet and exchange ideas, with more than 20,000 attendees, designed to meet the needs of the industry in 2021. FAMAR presented to a global audience its manufacturing and development services to the Pharmaceutical and Healthcare industry and committed to deliver innovative and accessible solutions for the improvement of patients’ and consumers’ lives, always next to its customers’ needs. FAMAR’s CEO, Mr. Ian Cooper, dynamically participated during the 3rd day of the event through a podcast interview with subject “The CDMO Response to COVID-19”. As he stated “To be successful in today’s landscape, CDMOs more than ever, must provide flexibility, collaboration and innovation, which requires continuously evolving our capabilities to ensure a solid delivery of drug development and manufacturing services. CDMOs must be ready to take on new challenges, having the financial background that safeguards the fundamental investments that are essential in the business, while at the same time having the substantial amount of expertise and provide value-added benefits. ” --- - Published: 2020-03-20 - Modified: 2025-05-13 - URL: https://www.famar-group.com/new/york-elements-acquisition-famar/ Funds managed by York Capital Management (York) and Elements Capital Management (ECM) have together completed the acquisition of the southern perimeter of the Famar business - a leading provider of contract manufacturing and development services to the pharmaceutical and health and beauty industry. The significant transaction that completed on March 20th, includes Famar’s facilities in Greece, Spain and Italy as well as the distribution business in Greece, which in total represents a turnover of €210M and 1900 employees. ECM and York have already injected considerable new capital into the companies to strengthen relationships with their commercial partners, and refocus on capital investment. A spokesperson for York and ECM said: “The team from York, ECM and their advisors have been most impressed with the leadership and employee commitment to the business. We are very confident that we can build a successful future for the business, the employees, our customers and all the other stakeholders. “We would also like to add our thanks to the hard work of the many people involved in making this transaction possible. ” The key leadership appointments in the new company are Ian Cooper (CEO), Kostas Reggis (COO), and Marnix Borghouts (CFO). Jeff Morrod will Chair the Board of Directors The firms advising York and ECM on the deal include global law firm, Reed Smith (lead deal counsel), Ernst & Young, Pérez-Llorca (Spain), Legance (Italy), Papapolitis & Papapolitis (Greece) and IQVIA. About York and ECM York, a global investment management firm with $18bn of assets under management... --- - Published: 2019-11-18 - Modified: 2025-05-13 - URL: https://www.famar-group.com/new/delpharm-acquisition-of-5-famar-sites/ Press release Delpharm and the Famar Group announce the acquisition by Delpharm of 5 manufacturing sites in France, Canada and the Netherlands Paris, November 18, 2019 – Delpharm and the Famar Group are pleased to announce the acquisition by Delpharm of 5 manufacturing sites belonging to Famar, in France, Canada and the Netherlands. The transaction signed today covers the French sites located in Orléans (Loiret), L’Aigle (Orne) and Saint-Rémy-sur-Avre (Eure-et-Loire), as well as the Montreal site in Canada and that of Bladel in the Netherlands. The group of 5 sites represents a turnover of 250M€ and 1,300 employees. Patrick Puy, President of Famar: « This acquisition by Delpharm, a reputable CDMO, represents a great opportunity for the 1300 Famar colleagues and will allow the sites to foresee a fruitful and sustainable future. » Sébastien Aguettant, President of Delpharm: « With an headcount of 4700 people working on 17 manufacturing sites, Delpharm is reaching a new level and is now part of the top 5 CDMOs worldwide. » Delpharm and the Famar Group wish to thank all the stakeholders who worked hard to make this deal happen, especially the French authorities, for their positive involvement. About Delpharm Delpharm is a European leader in contract manufacturing and development of medicines for pharmaceutical laboratories. It owns 17 manufacturing plants (12 in France, 2 in Italy, 1 in Belgium, 1 in the Netherlands and 1 in Canada) providing the majority of dosage forms available on the market: tablets, syrups, bottles, vials, etc. Including the... --- - Published: 2016-04-12 - Modified: 2024-12-13 - URL: https://www.famar-group.com/new/ecovadis-2016-assessment/ Pleased to announce that Famar Group has been awarded for the 2nd consecutive year at the Silver level by Ecovadis, our recognized partner assessing our Social Responsibility Program. Famar has shown an improved overall score compared to last year, mainly in the sustainable procurement area. The Ecovadis methodology framework assesses the policies and measures put in place, as well as the reporting published by companies with regards to environmental, labor practices & human rights, fair business practices and sustainable procurement based on 21 CSR criteria. --- - Published: 2015-10-07 - Modified: 2024-12-13 - URL: https://www.famar-group.com/new/ecovadis-gold-recognition/ Consistent to its goal to become a leading manufacturer and service provider to the Health & Personal Care Industry, Famar is continuously pursuing the development of its Corporate Social Responsibility. While maintaining the Silver Recognition by Ecovadis for Famar Group, two Famar sites (Alcorcon and Orleans La Source) have been awarded with Gold Recognition Level during the last six months. The Ecovadis methodology framework assesses the policies and measures put in place as well as the reporting published by companies with regards to environmental, labor practices & human rights, fair business practices and sustainable procurement, based on 21 CSR criteria. --- - Published: 2015-03-31 - Modified: 2024-12-13 - URL: https://www.famar-group.com/new/famar-silver-recognition-by-ecovadis/ In line with Famar’s strategic goal to become the leading manufacturer and service provider to the Health & Personal Care Industry, Famar has been awarded "Silver Recognition Level" following the first assessment conducted by Ecovadis in January 2015 on Corporate Social Responsibility. The Silver Recognition Level is based on Ecovadis rating on 21 Corporate Social Responsibility (CSR) criteria. The Ecovadis methodology framework assesses the policies and measures put in place as well as the reporting published by companies with regards to environmental, labor practices & human rights, fair business practices and sustainable procurement. Following this first successful rating, Famar is pursuing the development of its Corporate Social Responsibility. --- - Published: 2015-02-17 - Modified: 2024-12-13 - URL: https://www.famar-group.com/new/famar-serialization-project/ Regulatory authorities have defined (or are in the process of defining) requirements for the serialization for pharmaceutical products and tamper evidence, in an effort to address falsified medicines and reimbursement frauds. The implementation plan and specific requirements may vary for each market. For the majority of the markets (including EU), the new regulation is expected to be effective by 2018, according to the latest EU announcement. FAMAR is preparing on time, for the new regulatory requirements and has put in place since 2013 a global cross-functional team (Engineering, Information Systems, Quality & Supply Chain) to manage the project. We are making a significant investment in our packaging operations and Information Systems infrastructure to support serialization requirements. In the coming years, the new technology will be deployed on most of our packaging lines across all our sites. In January 2015, we completed successfully the production of the 1st serialized batch for the Korean market, in our manufacturing site in St-Remy, following the close cooperation with our customers and suppliers. Our objective is to implement a cost effective, high quality and flexible solution and transform this challenge to an opportunity which will increase the benefit to our customers. --- - Published: 2014-12-03 - Modified: 2025-05-13 - URL: https://www.famar-group.com/new/famar-manufacturing-science-tech-organization/ FAMAR launching Manufacturing Science & Technology organization Within the frame of our continuing effort to strengthen Quality and Knowledge management, we are pleased to announce that the Manufacturing Science & Technology (MS & T) organization has been formed. The initiative for the establishment of the MS & T organization as a distinct department is in compliance with our strategic Customers expectations and in alignment with their own respective organizations in this area. The MS & T will be part of Global Quality organization. The mission of MS & T will be to provide Quality support in:1. New Product Introduction & process transfers in close partnership with Operations, Product Transfer , Business Development (BD) and R & D teams. 2. Existing products and processes, in close collaboration with Operations and BD 3. The BU´s, in maintaining compliance in existing, mature products. 4. Assisting BU´s in customer interface in troubleshooting and resolving technical and quality issues, associated with Product Manufacturing and Analytical processes. 5. Proactively assisting in the improvement of legacy products, by improving robustness, prevent future problems, manage knowledge of core skills within FAMAR. 6. New Technologies and future opportunities/ services both in Manufacturing and in Analysis. 7. Sterile Manufacturing Continuous Improvement program. --- - Published: 2012-06-25 - Modified: 2025-05-13 - URL: https://www.famar-group.com/new/famar-expansion-new-sterile-area-madrid/ Famar is pleased to announce the successful certification and start of its new sterile area at its Madrid site. This project, initiated after the site acquisition in July 2011, strengthens and diversifies Famar’s production capacities for sterile products with the addition of up to 3 lines for the aseptic fill and finish of ophthalmic, ear and nasal products (spray and drops). As scheduled, the new 1000m² sterile workshop, currently set with 2 formulation areas, 1 filling line and 1 packaging line will be extended this summer with a second full fill and finish line. With all three lines installed, the new area will provide a total capacity of 40Mio packs. After the Lyophilization extension capacity performed in 2008 and 2010 at the Saint Rémy sur Avre site -France, Famar is achieving another key milestone in its development strategy for Sterile forms. Should you need any additional clarifications or information about our services, please contact Nadège NIEF (n. nief@fr. famar. gr ) or Kyriakos KANSOS (k. kansos@famar. gr). --- - Published: 2011-07-14 - Modified: 2025-05-13 - URL: https://www.famar-group.com/new/famar-integration-madrid-operations-expansion/ The integration of the Sanofi-Aventis manufacturing site in Madrid within Famar network is now official. As of July 1st the two parties came to a written agreement finalizing the framework and the principles of the collaboration. The site, which produces both solid and sterile forms and supplies more than 50 markets, will serve as an additional platform for developing Famar’s service offering. Famar will continue to supply Sanofi-Aventis with certain products from the site on the basis of a strong and sustainable supply agreement. In addition, as part of this project, Famar has launched a significant investment plan to expand the plant’s sterile capacities and offering. The plan involves the creation of a new 1000m2 sterile core with two compounding rooms, linked to three filling and packaging lines. The new are will be focused on sterile ophthalmic and nasal spray products with an annual capacity ranging between 30 and 35 mio consumer units. The area will be operational at the end of Q4 2011. --- - Published: 2004-06-15 - Modified: 2025-05-13 - URL: https://www.famar-group.com/new/efqm-commitment-to-excellence-famar/ Famar received its first Recognition in the EFQM Levels of Excellence. The division "Logistics Services" of Famar succeeded in meeting all criteria of the European program of Recognition of EFQM "Committed to Excellence". The recognition was awarded to Famar on May 1st, 2004 and lasts for 2 years. The certificate of the Recognition was received during an official ceremony, on June 3rd, 2004. Our journey to Excellence has just begun! The EFQM “Commitment to Excellence” recognition verifies that we have been committed to continuous self-assessment and organizational improvement programs, aiming at becoming best in class. EFQM is a not-for-profit membership foundation. Based in Brussels with members and valued partners situated in every geographical region across the globe, EFQM helps European businesses make better products and deliver improved services through the effective use of leading edge management practices. --- --- ## Sites --- ## Manufacturing ---